The cDNA of human Cav-3 was amplified by polymerase chain reaction (PCR), and the cDNA was ligated into a pET16b vector using two restriction endonuclease sites, Nco I and BamH1.
seed 1 L of M9 minimal medium culture, which contained ampicillin, chloramphenicol, glucose, MEM vitamins, 0.1 mM CaCl2, 1 mM MgSO4, and 15 NH4Cl for isotopic labeling. Large-scale cultures were then grown at room temperature until the OD600 reached 0.65-0.75. Protein expression was induced with the addition of 1 mM IPTG to the cultures. Following 24 hours of induction the cells were harvested by centrifugation. Expression of recombinant Cav3 was confirmed both by Western blot using a monoclonal anti-5X His mouse antibody (Cell Signaling Technology, Danvers, MA) and by mass spectrometry (of the purified protein, see below).
Purification of Human Cav3
Harvested cells were resuspended in 20ml lysis buffer (75 mM Tris, pH 7.8, 300 mM NaCl) per gram of wet cells. The lysis buffer also contained 2 mM ethylenediaminetetraacetic acid (EDTA), 5 mM magnesium acetate, 2 mg/mL lysozyme, 0.2 mg/mL DNase and RNase, and either 50 μL of protease cocktail inhibitor (Sigma-Aldrich, St. Louis, MO) or 0.2ml of phenylmethylsulfonyl fluoride (PMSF) per gram of cells. The suspension was tumbled for 90 min at room temperature followed by sonication on ice for 5 min with a 50% duty cycle at approximately 57 W using a Misonix sonicator (Farmingdale, NY). Inclusion bodies were pelleted by centrifugation at 20,000 rpm for 30 min using a Beckman-Coulter JA 25.5 rotor (approximately 48,000g) (Indianapolis, IN). The inclusion bodies were then solubilized in 20 mL of buffer A (40 mM HEPES pH 7.8 and 300 mM NaCl) containing 3%
(v/v) Empigen detergent (Sigma-Aldrich, St. Louis, MO) per gram of cells. The solution was then tumbled at 4°C until the mixture clarified (approximately 2 h) and then centrifuged to remove any remaining insoluble particulates. Ni-NTA resin (1.2 mL/g of cells) was equilibrated with buffer A and then added to the supernatant. The mixture was then tumbled for 1 h at room temperature. The resin was loaded into a chromatography column and sequentially washed with buffer A containing 3% (v/v) Empigen and buffer A containing 40 mM imidazole and 1.5% (v/v) Empigen, which eluted non-His6tagged proteins from the resin. Empigen was then exchanged for other detergents by re-equilibrating the column with 12 column volumes of 20 mM sodium phosphate (pH 7.2) containing either 0.5% βn-decylmaltoside (DM), 0.5% dodecylphosphocholine (DPC), 0.2% n-tridecylphosphocholine (Fos-3 13), 0.2% n-tetradecylphosphocholine (TDPC), 0.2% lyso-lauroylphosphatidylcholine (LLPC), 0.2% lyso-myristoylphosphatidylcholine (LMPC), 0.1% lyso-palmitoylphosphatidylcholine (LPPC), 0.2% lauryldimethylamine oxide (LDAO), 0.1% lyso-myristoylphosphatidylglycerol (LMPG), or 0.1% lyso-palmitoylphosphatidylglycerol (LPPG). Cav-3 was then eluted from the column with 250 mM imidazole (pH 7.8) and 2mM DTT containing the corresponding detergent in the elution buffer. After adjusting the pH by adding acetic acid, the eluted protein was concentrated at 20 °C using a centrifugal concentrator (10 kDa Amicon Ultra 4ml, EMD Millipore).
Mutagenesis of Cav3
Cav3 has nine native cysteine residues, the 5 th , 6 th , and 8 th of which are known to undergo palmitoylation (C106, C116 and C129). In order to facilitate the specific addition of lipid chains to only these sites, the six natively un-modified cysteine residues were mutated to serine or alanine as follows: C19S, C72A, C94A, C98A, C124S and C140S. The cysteine residues located in membrane domain were replaced with Ala and the others with Ser to match the expected local solvent polarity experienced by these residues [1] . Mutant variants were generated by site-directed mutagenesis using the QuikChange site-directed mutagenesis kit.
Lipidation of Cav3
The method used to lipidate Cav3 is outlined in Figure 1 . Ellman's reagent (5,5' -dithio-bis-(2-nitrobenzoic acid) (DTNB), a compound commonly used for sulfhydryl quantification [2] , was dissolved to a final concentration of 20 mM in 100 mM sodium phosphate buffer (pH 7.2). 1.5 ml of the DTNB solution was mixed with 300-400 μL of a concentrated solution containing 1-2 mg of purified Cav3 in 250 mM imidazole (pH 7.8), 1 mM EDTA and 2 mM DTT. 60ul of a 100 mM EDTA (pH 7.2) stock solution was then added, and the total volume was then adjusted to 3 ml with 20 mM sodium phosphate (pH 7.2). The final reaction solution typically contained 30-80 μM protein, 10 mM DTNB, and 5 mM EDTA. The mixture was then tumbled for 4 h at room temperature, leading to formation of disulfide bonds between cysteine thiols and thionitrobenzoate (TNB), the latter of which is a high energy leaving group. The sample was then loaded on an Econo-Pac 10DG buffer exchange column of 10 ml bed volume, which was pre-equilibrated with 0.2% LPPG and 25 mM sodium phosphate buffer (pH 7.2). This removes unreacted DNTB as well as free TNB. The TNB-modified protein was eluted in about 4 ml of buffer, as monitored by A280, and octanethiol or tetradecanethiol were added to the elution pool to a final concentration of 10 mM followed by a 5 h incubation.
Thionitrobenzoate-activated cysteine thiols of Cav3 reacted with octanethiol to exchange disulfide bonds to link cysteine thiols to octanethiol, releasing the free thiolate form of thionitrobenzoate. The mixture was then tumbled for 1 h with Ni-NTA resin equilibrated in 25 mM sodium phosphate (pH 7.2). The resin was then loaded into a chromatography column and rinsed with 15 column volumes of 25 mM sodium phosphate (pH 7.2) containing 0.2% LPPG to remove free thiols and thiobenzoate.
The tri-octylated protein was then eluted from the column with 250 mM imidazole (pH 7.8) containing 0.2% LPPG. The eluted protein was then concentrated using a centrifugal concentrator at 20 °C and exchanged with the final buffer containing 100 mM imidazole (pH 6.5) and 1 mM EDTA. 
Far-UV Circular Dichroism (CD)
CD spectra were acquired using a Jasco J-810 spectropolarimeter equipped with a Peltier temperature control. Samples were purified as described above and exchanged into 25 mM sodium phosphate buffer (pH 6.5) containing 100mM NaCl, 0.5mM EDTA, 1mM TCEP and 0.2% LPPG using an Econo-Pac 10DG column (Bio-Rad). TCEP was omitted from the buffer of the lipidated 5 samples. CD spectra were acquired from 250 to 190 nm at 25°C with a protein concentration of 8.5 uM using a 1 mm path length cuvette. α helical and β strand content was estimated from the CD spectra using the K2D3 algorithm [3] .
NMR Spectroscopy
1D proton NMR spectra were assessed in order to determine the final detergent concentration in the samples. The ratio of the integral of detergent alkyl or acyl chain hydrogens to that of the DSS standard was calculated for each sample. To calculate the final detergent concentration, this ratio was then compared to the ratios calculated for a series of reference samples containing 0.1, 0.5, 1, 2.5, 5 and 10% LPPG and 1.5mM DSS. Final LPPG concentrations typically ranged between 3-6%. 2-D 1 H, 15 N-TROSY NMR spectra [4] were acquired using Bruker 600, 800, or 900 MHz spectrometers equipped with TXI cryoprobes. NMR data were processed with NMRPIPE [5] and analyzed using SPARKY [6] .
TCEP titration NMR measurement
To assess the specificity of the perturbations arising from lipidation, the reducing agent TCEP (pH 6.5) was added to the lipidated 568C-Cav3 NMR sample to a final concentration of 10 mM, and 1 H-15 N HSQC spectra of lipidated 568C Cav3 was recorded following 0 and 34 hours of equilibration.
NMR relaxation analysis
The longitudinal relaxation rate (R1) and the transverse relaxation rate (R2) of backbone 15 N nuclei, as well as the heteronuclear NOEs (hetNOE) between amide 15 N and 1 H nuclei were assessed using established HSQC based NMR pulse sequences [7] . Relaxation experiments were performed at 900 MHz (21.2 Tesla). T1 values were measured from 1 H-15 N correlation spectra recorded with 6 relaxation evolution delays of 100, 250, 500, 800, 1200, 2000, 4000, and 8000 ms. A 3.5 s delay was used between scans. T2 values were measured from 1 H-15 N correlation spectra recorded using relaxation evolution delays of 16, 32, 48, 64, 80, 112, 144 and 192 ms. A delay of 3.5 s was used between scans. The steady state 1 H-15 N hetNOE values were determined from peak ratios observed between the two spectra, which were collected with or without a pre-saturation of the proton dimension. Figure S2 . The far-UV Circular Dichroism (CD) spectra of wild-type (black circles), 568C-Cav3 (red triangles), and lipidated 568C-Cav3 (blue squares) was recorded at 25° C and is plotted against the wavelength in nm. Samples contained LPPG micelles. We then utilized the K2D3 algorithm to assess the secondary structure content of wild-type Cav3 (49 % α helix and 8 % β sheet), 568C-Cav3 (47 % α helix and 10 % β sheet), and lipidated 568C-Cav3 (48 % α helix and 9 % β sheet) suggested by these spectra. The calculated secondary structure is therefore deemed to be the same, within experimental uncertainty, for each construct. cyan spectrum was collected starting immediately after adding TCEP (but required 5 hours to collect), while the blue spectrum (also requiring 5 hours to collect) was acquired starting 34 hours after adding TCEP. The chemical shift perturbations of the resonances of I95, I100, A102, and I107 caused by lipid modifications were reversed upon equilibration in the presence of TCEP, which is likely due to the reduction of the lipid modification at residue C106. Similar reversions were observed in the resonances corresponding to S109 and I112, though the presence of kinetic intermediates in this case suggest that these perturbations likely caused by multiple lipid modifications (perhaps both modifications at C106 and C116). Reversions of the chemical shifts associated with the resonances of S118 and S124 were apparent and likely correspond to the reduction of the modification at residue C116. Reversion of the chemical shifts associated with the resonances of residues T127, L132, F133 and A134 were apparent, and the position of these residues along with the presence of kinetic intermediates suggests that the perturbations in these residues arise as a result of the modifications at both C116 and C129. The resonances of I132 and A134, which were not present in the spectrum of non-lipidated 568C-Cav3, were shifted after a 34 hr equilibration with TCEP but not completely absent, suggesting the complete reduction of the modification at residue C129 might be quite slow. The peaks for A102 and S118 that correspond to the lipidated and non-lipidated species in the spectrum of lipidated 568C-Cav3 spectra were integrated, and suggest yields of about 88% and 76% for the lipidation of C106 and C116, respectively. Due to the fact that the resonance associated with F133 in the non-lipidated species was not present in the spectrum of lipidated 568C-Cav3, the lipidation of C129 appears to be >90% efficient. Because the total population of incompletely modified protein is minor and contains multiple forms (each with a different combination of lipidated and non-lipidated cysteine residues, each with its own NMR spectrum), the observed spectrum is dominated by the fully-modified species carrying three acyl chain modifications. This makes interpretation of the data in terms of the behavior of the completely lipidated protein straightforward. All spectra were acquired at pH 6.5, 318K and 900MHz. 
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